Anti-VEGF AAV2 injections: The fewer the better.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 28592565.
- Also identified by DOI 10.1126/scitranslmed.aan4921.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A single intravitreal injection of AAV2 provides sustained delivery of anti-VEGF protein for the treatment of neovascular AMD.
Medical subject headings
- Vascular Endothelial Growth Factor A
- Wet Macular Degeneration